A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Updated 04/23/2024

Status Completed

Clinical Trial Summary

A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03988335
Study type	Interventional
Source	Aristea Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	February 13, 2019
Completion date	November 19, 2019

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT04493424` - A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab	Phase 2
	Recruiting	`NCT05994976` - Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
	Completed	`NCT04572997` - Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)	Phase 2
	Completed	`NCT03633396` - A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis	Phase 2
	Active, not recruiting	`NCT05174065` - Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)	Phase 3
	Active, not recruiting	`NCT04459507` - A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
	Completed	`NCT01780857` - Immune Signature of Palmoplantar Pustulosis	N/A
	Completed	`NCT03972280` - Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis	Phase 1
	Completed	`NCT01794117` - Anakinra for Inflammatory Pustular Skin Diseases	Phase 2
	Recruiting	`NCT05710185` - Deucravacitinib for the Treatment of Palmoplantar Pustulosis	Phase 4
	Terminated	`NCT05194839` - A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)	Phase 2
	Active, not recruiting	`NCT04566471` - Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence
	Completed	`NCT02641730` - An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis	Phase 3
	Completed	`NCT04061252` - A Study of KHK4827 in Subjects With Palmoplantar Pustulosis	Phase 3